Homozygous deletions of p16(INK4) occur frequently in bilharziasis-associated bladder C

International Journal of Cancer

Volumn 68, Issue 2, 1996, Pages 183-187

  Tamimi, Yahya ^a   Bringuier, Pierre Paul ^a   Smit, Frank ^a   Van Bokhoven, Adrie ^a   Abbas, Ahmed ^b   Debruyne, Frans M J ^a   Schalken, Jack A ^a,c  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MANSOURA UNIVERSITY   (Egypt)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLADDER CANCER; CONTROLLED STUDY; EGYPT; GENE DELETION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; NETHERLANDS; PRIORITY JOURNAL; SCHISTOSOMA;

CARRIER PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; EGYPT; GENE DELETION; HUMANS; NETHERLANDS; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; SCHISTOSOMIASIS; URINARY BLADDER NEOPLASMS;

EID: 0029798357     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19961009)68:2<183::AID-IJC7>3.0.CO;2-U     Document Type: Article

References (40)

1. INK4 and retinoblastoma tumor-suppressor genes occur in distinct subset of human cancer cell lines. Int. J. Cancer, 61, 115-120 (1995).
2. ABERLE, H. and 13 OTHERS, The human plakoglobin gene localizes on chromosome 17q21 and is subjected to loss of heterozygosity in breast and ovarian cancers. Proc. nat. Acad. Sci. (Wash.), 92, 6384-6388 (1995).
3. BADAWI, A.F., MOSTAFA, M.H., ABOUL-AZM, T., HABOUBI, N.Y., O'CONNOR, P.J. and COOPER, D.P., Promutagenic methylation damage in bladder DNA from patients with bladder cancer associated with schistosomiasis and from normal individuals. Carcinogenesis, 13, 877-881 (1992).
4. BRINGUIER, P.P., TAMIMI, Y., SCHUURING, E. and SCHALKEN, J.A., Expression of cyclin D1 and EMS1 in bladder tumours; relationship with chromosome 11q13 amplification. Oncogene, 12, 1747-1753 (1996).
5. CAIRNS, P., MAO, L., MERLO, A., LEE, D.J., SCHWAB, D., EBY. Y., TOKINO, K., VAN DER RIET, P., BLAUGRUND, J.E. and SIDRANSKY, D., Rates of p16 (MTS1) mutations in primary tumors with 9p loss. Science, 265, 415-417 (1994).
6. CANNON-ALBRIGHT, L.A., GOLDGAR, D.E., MEYER, L.J., LEWIS, C.M., ANDERSON, D.E., FOUNTAIN, J.W., HEGI, M.E., WISEMAN, R.W., PETTY, E.M. and BALE, A.E., Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-22. Science, 258, 1148-1152 (1992).
7. CANNON-ALBRIGHT, L.A., GOLDGAR, D.E., NEUHAUSEN, S., GRUIS, N.A., ANDERSON, D.E., LEWIS, C.M., JOST, M., TRAN, T.D., NYGUEN, K. and KAMB., A., Localization of the 9 p melanoma susceptibility locus (MLM) to a 2-cM region between D9S736 and D9S171. Genomics, 23, 265-268 (1994).
8. INK4 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma. Cancer Res., 54, 5547-5551 (1994).
9. DE TAISNE, C., GEGONNE, A., STEHELIN, D., BERNHEIM, A. and BERGER, R., Chromosomal localization of the human proto-oncogene c-ets. Nature (Lond.), 310, 581-583 (1984).
10. FRANKE, W.W., GOLDSCHMIDT, M.D., ZIMBELMANN, R., MUELLER, H.M., SCHILLER, D.L. and COWIN, P., Molecular cloning and aminoacid sequence of human plakoglobin, the common junctional plaque protein. Proc. nat. Acad. Sci. (Wash.), 86, 4027-4031 (1989).
11. GENTILE, J.M., Schistosomiasis related cancer: a possible role for genotoxins. Environ. Mutagenesis, 7, 775-785 (1985).
12. GIANI, C. and FINOCCHIARO, G., Mutation rate of CDKN2 gene in malignant gliomas. Cancer Res., 54, 6338-6339 (1994).
13. INK4B gene) during tumor progression in a sporadic melanoma patient. Cancer Res., 55, 5531-5535 (1995).
14. GONZALEZ-ZULUETA, M., SHIBATA, A., OHNESEIT, P.P., SPRUCK, C.H., BUSCH, C., SHAMAA, M., ELBAZ, M., NICHOLS, P.W., GONZALGO, M.L., MALMSTROM, P.U. and JONES, P.A., High frequency of chromosome 9p allelic loss and CDKN2 tumor suppressor gene alterations in squamous cell carcinoma of the bladder. J. nat. Cancer Inst., 87, 1383-1393 (1995).
15. GRUIS, N.A., VAN DER VELDEN, P., SANDKUIJL, L.A., PRINS, D.E., WEAVER-FELDHAUS, J., KAMB, A., BERGMAN, W. and FRANTS, R.R., Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds. Nature (Genet.), 10, 351-353 (1995).
16. HERLYN, M., Molecular and cellular biology of melanoma. In: C. Kerkaporta (ed.), Medical intelligence unit, pp. 1-98, CCR Press, Austin, TX (1993).
17. HOLLAND, E.A., BEATON, S.C., BECKER, T.M., GRULET, O.M.C., PETERS, B.A., Rizos, H., KEFFORT, R.F. and MANN, G.J., Analysis of p16 gene, CDKN2 in 17 Australian melanoma kindreds. Oncogene, 11, 2289-2294 (1995).
18. HUSSUSSIAN, C.J., STRUEWING, J.P., GOLDSTEIN, A.M., HIGGINS, P.A.T., ALLY, D.S., SHEAHAN, M.D., CLARK, W.H., TUCKER, M.A. and DRACOPOLI, N.C., Germline p16 mutations in familial melanoma. Nature (Genet.), 8, 15-21 (1994).
19. IGAKI, H., SASAKI, H., TACHIMORI, Y., KATO, H., WATANABE, H., KIMURA, T., HARADA, Y., SUGIMURA, T. and TERADA, M., Mutation frequency of the p16/CDKN2 gene in primary cancers in the upper digestive tract. Cancer Res., 55, 3421-3423 (1995).
20. JEN, J., HARPER, J.W., BIGNER, S.H., BIGNER, D.D., PAPADOPOULOS, N., MARKOWITZ, S., WILLSON, J.K.V., KINZLER, K.W. and VOGELSTEIN, B., Deletion of p16 and p15 genes in brain tumors. Cancer Res., 54, 6353-6358 (1994).
21. KAMB, A., Cell-cycle regulators and cancer. Trends Genet., 11, 136-140 (1995).
22. KAMB, A., GRUIS, N.A., WEAVER-FELDHAUS, J., LIU, Q., HARSHMAN, K., TAVTIGIAN, S.V., STOCKERT, E., DAY, R.S., JOHNSON, B.E. and SKOLNICK, M.H., A cell cycle regulator potentially involved in genesis of many tumor types. Science, 264, 436-440 (1994a).
23. KAMB, A. and 23 OTHERS, Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nature (Genet.), 8, 22-26 (1994b).
24. KNOWLES, M.A. and WILLIAMSON, M., Mutation of H-ras is infrequent in bladder cancer: confirmation by single strand conformation polymorphism analysis, designed restriction fragment length polymorphisms and direct sequencing. Cancer Res., 53, 133-139 (1993).
25. MORI, T., MIURA, K., AOKI, T., NISHIHIRA, T., MORI, S. and NAKAMURA, Y., Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase-4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res., 54, 3396-3397 (1994).
26. NOBORI, T., MIURA, K., WU, D.J., LOIS, A., TAKABAYASHI, K. and CARSON, D.A., Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature (Lond.), 368, 753-756 (1994).
27. OHTA, M., NAGAI, H., SHIMIZU, M., RASIO, D., BERD, D., MASTRANGELO, M., SINGH, A.D., SHIELDS, J.A., SHIELDS, C.L., CROCE, C.M. and HUEBNER, K., Rarity of somatic and germline mutations of the cyclin-dependent kinase 4 inhibitor gene, CDK41 in melanoma. Cancer Res., 54, 5269-5272 (1994).
28. INK4/MTS1/CDKN2, p15/MTS2, and p18 genes in primary and metastatic lung cancer. Cancer Res., 55, 1448-1451 (1995).
29. RAMCHURREN, N., COOPER, K. and SUMMERHAYES, I.C., Molecular events underlying schistosomiasis-related bladder cancer. Int. J. Cancer, 64, 237-244 (1995).
30. ROSIN, P.A., ANWAR, W.A. and WARD, A.J., Inflammation, chromosomal instability, and cancer: the schistosomiasis model. Cancer Res. (Suppl.), 54, 1929s-1933s (1994).
31. INK4/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas. Cancer Res., 54, 6321-6324 (1994).
32. SERRANO, M., HANNON, G.J. and BEACH, D., A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature (Lond.), 366, 704-707 (1993).
33. INK4 gene in uncultured tumours. Nature (Lond.), 370, 183-184 (1994).
34. WALKER, D.G., DUAN, W., POPOVIC, E.A., KAYE, A.H., TOMLINSON, F.H. and LAVIN, M., Homozygous deletions of the multiple tumor suppressor gene 1 in the progression of human astrocytomas. Cancer Res., 55, 20-23 (1995).
35. WILLIAMSON, M.P., ELDER, P.A., SHAW, M.E., DEVLIN, J. and KNOWLES, M.A., p16 (CDKN2) is a major deletion target at 9p21 in bladder cancer. Hum. mol. Genet., 4, 1569-1577 (1995).
36. WORLD HEALTH ORGANIZATION, Possible basic mechanisms of carcinogenesis in schistosomiasis and other trematode infections. Technical Report Series WHO/Schisto. 1/84.75, WHO, Geneva (1983).
37. WORLD HEALTH ORGANIZATION, The control of schistosomiasis. Report of WHO Expert Committee. Technical Report Series 728, WHO, Geneva (1985).
38. WRIGHT, D.K. and MANOS, M.M., Sample preparation from paraffin-embedded tissues. In: M.A. Innis. D.H. Gelfond, J.J. Sninsky and T.J. White (eds.), PCR protocols, pp. 153-158, Academic Press, San Diego (1990).
39. XIAO, S., LI, D., CORSON, J.M., VIJG, J. and FLETCHER, J.A., Codeletion of p15 and p16 genes in primary non-small lung cancer. Cancer Res., 55, 2968-2971 (1995).
40. ZHOU, X., TARMIN, L., YIN, J., JIANG, H., SUZUKI, H., RHYU, M., ABRAHAM, J.M. and MELTEZER, S.J., The MTS1 gene is frequently mutated in primary human esophageal tumors. Oncogene, 9, 3737-3741 (1994).